Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Digital and AI

 

Interview with HTEC’s Alfred Olivares on AI adoption in healthcare

US-based digital product development and consulting firm HTEC recently queried 253 C-level healthcare and life sciences executives across the US, UK, Germany, Spain, Saudi Arabia and the UAE on how they are progressing with AI adoption. The ‘State of AI in Healthcare and Life Sciences 2025-2026’ survey found that almost all healthcare firms are trying to adopt AI tools, but most are running into difficulty in scaling them. Alfred Olivares, Managing Partner (HLS) at HTEC, spoke to us about some of the biggest technical and organisational challenges which are hampering businesses.
July 2, 2026

Prosus invests in French insurer Alan to help it expand internationally

Dutch technology investor Prosus has invested €400 million in French insurer Alan, acquiring a small minority stake. Prosus plans to be deeply involved in the insurer’s development and expansion, in particular helping it scale internationally in large markets where Prosus has a presence.
July 2, 2026

Doctify launches in Saudi Arabia

UK-based healthcare review platform Doctify has launched in Saudi Arabia, marking its seventh market and its second in the Gulf following the UAE. 
June 18, 2026

Huron acquires RelateCare from MML Ireland

Huron, a Nasdaq-listed global professional services firm, has acquired AI-enabled clinical and patient access solutions provider RelateCare from private equity firm MML Growth Capital Partners Ireland.
June 11, 2026

Interview with Niklas Kouparanis, founder and CEO of Europe’s largest medical cannabis digital health company, Bloomwell

Germany’s medical cannabis market has been booming since it was removed from the list of controlled narcotic substances in 2024, which made prescribing it much easier. Now as many as one million Germans are being prescribed cannabis, according to the most often cited figure by those in the industry. The majority of these prescriptions are being handed out by digital health companies specialising in cannabis. The largest of these companies is Bloomwell, who HBI sat down with last week at Cannabis Europa (a conference focused on medicinal cannabis).
June 4, 2026

France’s obesity drug reimbursement plan could reshape insurers’ role in care

France will begin reimbursing anti-obesity medicines from mid-June 2026, becoming the first EU country to introduce public coverage for treatments including Wegovy and Mounjaro, produced by Danish pharma giant Novo Nordisk and American pharmaceutical company Eli Lilly respectively. The policy is intended to prioritise high-risk patients rather than general weight management. Access will be limited to patients with severe obesity, defined as a BMI of at least 40, or at least 35 where accompanied by conditions such as type 2 diabetes or cardiovascular disease.
June 4, 2026

What does the £900m NHS AI framework mean for UK healthcare? 

A new major UK-wide framework for Healthcare AI Solutions, with a maximum spend ceiling of £750–900 million (~€867–1,040 mn) to be spent over eight years (2027–2035), has been launched. What does it mean for providers and investors?
June 4, 2026

Grundium acquires Visiopharm

Grundium, a Finland-based digital pathology imaging company backed by US private equity firm EW Healthcare Partners, has acquired Denmark-based AI precision pathology software provider Visiopharm. The deal aims to create an integrated digital pathology platform combining imaging and AI-driven diagnostics.
May 28, 2026

Bregal Sagemount and Ardian invest in Ennov

Ennov, a France-based life sciences software company, has secured a growth investment led by US private equity firm Bregal Sagemount, with participation from private investment firm Ardian.
May 27, 2026

Healthcare deal activity expected to be increasingly back-end loaded through 2026: Hedley Goldberg, Rothschild & Co

The global healthcare M&A landscape in 2026 sits at an unusual juncture. The wider economy is facing a lot of headwinds and feels increasingly uncertain, whilst the usual private equity strategies aren’t working as smoothly as before. Healthcare is still seen as one of the strongest sectors to invest in around the world, however, and may even benefit from the shift away from software and tech-enabled services. 
May 22, 2026
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us